N/A
Completed N=55
Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy
Source: ClinicalTrials.gov NCT02699554 ↗Enrolled (actual)
55
Serious AEs
0.0%
Results posted
May 2022
Primary outcomePrimary: Change in Walk Dynamic Motor Control Index 6-months After Orthopaedic Surgery — -2.4 normalized z-score
Summary
Impaired neuromuscular control hinders movement for individuals with cerebral palsy and other neurological disorders. In this research, the investigators are developing new tools to quantify impaired neuromuscular control in cerebral palsy and evaluate changes after one of the most common treatments, orthopaedic surgery. The results from this research will empower clinicians to identify patient-specific factors that contribute to impaired movement and improve treatment and quality of life.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Walk Dynamic Motor Control Index 6-months After Orthopaedic Surgery |
-2.4 | — |
| PRIMARY Change in Walk Dynamic Motor Control Index 1-year After Orthopaedic Surgery |
-2.7 | — |
| SECONDARY Change in Gait Deviation Index 6-months After Orthopaedic Surgery |
2.8 | — |
| SECONDARY Change in Gait Deviation Index 1-year After Orthopaedic Surgery |
2.1 | — |
Eligibility Criteria
Inclusion Criteria
- Diplegic cerebral palsy
- Mild or Moderate Impairment, Gross Motor Function Classification System (GMFCS) Levels I-III
- Will receive follow-up care and physical therapy within the Gillette Children's Specialty Healthcare system
Exclusion Criteria
- Botulinum toxin injections, baclofen, or other similar treatments in the 3 months prior to pre-operative gait analysis
Data sourced from ClinicalTrials.gov (NCT02699554). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.